KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Other Operating Expenses (2016 - 2025)

Globus Medical (GMED) has disclosed Other Operating Expenses for 15 consecutive years, with -$372.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 31.94% year-over-year to -$372.7 million, compared with a TTM value of -$1.1 billion through Dec 2025, up 9.51%, and an annual FY2024 reading of -$1.2 billion, down 744.63% over the prior year.
  • Other Operating Expenses was -$372.7 million for Q3 2025 at Globus Medical, up from -$384.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $88.8 million in Q4 2023 and bottomed at -$512.0 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is -$136.7 million, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses soared 240.14% in 2021, then crashed 16861.76% in 2024.
  • Year by year, Other Operating Expenses stood at $10.0 million in 2021, then crashed by 5237.29% to -$512.0 million in 2022, then skyrocketed by 117.35% to $88.8 million in 2023, then plummeted by 466.79% to -$325.8 million in 2024, then dropped by 14.42% to -$372.7 million in 2025.
  • Business Quant data shows Other Operating Expenses for GMED at -$372.7 million in Q3 2025, -$384.0 million in Q2 2025, and -$297.1 million in Q1 2025.